# Mission Pharmacal Company, Boerne, TX – FDA Inspections

Source: https://www.keypedia.com/companies/mission-pharmacal-company/91da96fe-b7e4-449c-b2cc-53a57bd7f2b6

> Inspection records and compliance data for Mission Pharmacal Company in Boerne, Texas. 9 FDA inspections on record (1 OAI), 1 Form 483, last inspected June 27, 2023.

---

## Details

- Name: Mission Pharmacal Company
- FEI Number: 3000204446
- Business Operations: FDF MANUFACTURE
- Address Line 1: 38505 Interstate 10 W
- City: Boerne
- State: Texas
- Zip Code: 78006
- Country Name: United States
- Address: 38505 Interstate 10 W, Boerne, Texas 78006, United States
- Country: United States

## Related Documents

- FDA Inspection 1219105 - Mission Pharmacal Company - 2023-06-27 — classification: No Action Indicated (NAI), source: FDA, date: June 27, 2023
- [483 - Mission Pharmacal Company - 2022-09-22](https://www.keypedia.com/records/483/mission-pharmacal-company/c1fa42f1-b5d4-43b9-a7ab-c65cbe41084c) — source: FDA, date: September 22, 2022
- [FDA Inspection 1180935 - Mission Pharmacal Company - 2022-09-22](https://www.keypedia.com/records/fda_inspections/mission-pharmacal-company/8319387b-93ab-42e5-9d7e-44089969d14c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 22, 2022
- [483 - Mission Pharmacal Company - 2019-04-04](https://www.keypedia.com/records/483/mission-pharmacal-company/de4b9fd5-1991-46a8-aef1-60b534e3f5c9) — source: FDA, date: April 4, 2019
- [FDA Inspection 1085124 - Mission Pharmacal Company - 2019-04-04](https://www.keypedia.com/records/fda_inspections/mission-pharmacal-company/9828023a-ad18-41ad-b502-0f962d22608b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 4, 2019
- [EIR - Mission Pharmacal Company - 2018-09-20](https://www.keypedia.com/records/eir/mission-pharmacal-company/f243b35b-0d26-401e-943e-054730b74083) — source: FDA, date: September 20, 2018
- FDA Inspection 1067651 - Mission Pharmacal Company - 2018-09-20 — classification: No Action Indicated (NAI), source: FDA, date: September 20, 2018
- [FDA Inspection 1067651 - Mission Pharmacal Company - 2018-09-20](https://www.keypedia.com/records/fda_inspections/mission-pharmacal-company/558027af-5b62-496d-a991-0175c5a4846e) — classification: No Action Indicated (NAI), source: FDA, date: September 20, 2018
- [EIR - Mission Pharmacal Company - 2017-05-04](https://www.keypedia.com/records/eir/mission-pharmacal-company/3401cfdc-0828-4576-a5a3-4e3347c881be) — source: FDA, date: May 4, 2017
- FDA Inspection 1019109 - Mission Pharmacal Company - 2017-05-04 — classification: No Action Indicated (NAI), source: FDA, date: May 4, 2017
- FDA Inspection 1019109 - Mission Pharmacal Company - 2017-05-04 — classification: No Action Indicated (NAI), source: FDA, date: May 4, 2017
- [FDA Inspection 1019109 - Mission Pharmacal Company - 2017-05-04](https://www.keypedia.com/records/fda_inspections/mission-pharmacal-company/c221bfd4-0ff6-4b79-b9cb-04276bae4388) — classification: No Action Indicated (NAI), source: FDA, date: May 4, 2017
- [EIR - Mission Pharmacal Company - 2016-04-04](https://www.keypedia.com/records/eir/mission-pharmacal-company/e3fc2291-f7d5-4e0f-821f-ca635812b960) — source: FDA, date: April 4, 2016
- [EIR - Mission Pharmacal Company - 2014-02-07](https://www.keypedia.com/records/eir/mission-pharmacal-company/c93b376c-87a4-4f1c-a091-b28dd4af1e17) — source: FDA, date: February 7, 2014
- [483 - Mission Pharmacal Company - 2014-02-07](https://www.keypedia.com/records/483/mission-pharmacal-company/4a5b0198-5b64-4f4b-8326-3e1ac06b0f95) — source: FDA, date: February 7, 2014
- FDA Inspection 866629 - Mission Pharmacal Company - 2014-02-07 — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2014
- FDA Inspection 866629 - Mission Pharmacal Company - 2014-02-07 — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2014
- [483 - Mission Pharmacal Company - 2012-05-25](https://www.keypedia.com/records/483/mission-pharmacal-company/0baf761c-5141-4187-9f2f-099e78a6b8f1) — source: FDA, date: May 25, 2012

## Related Companies

- [Pharmco Laboratories Inc.](https://www.keypedia.com/companies/pharmco-laboratories-inc/b34e3481-0ea5-433a-9e03-ce66b44df443)
- [Llorens Pharmaceuticals International Division, Inc.](https://www.keypedia.com/companies/llorens-pharmaceuticals-international-division-inc/3bc4594c-275f-4451-9cf8-4e2e9bc14ee4)
- [Denison Pharmaceuticals, LLC](https://www.keypedia.com/companies/denison-pharmaceuticals-llc/c217e50a-bd7d-49c3-8f66-2bf20a1c71ec)
- [CoreRX Inc.](https://www.keypedia.com/companies/corerx-inc/cca4f858-9ccd-498a-893b-22c5d29559aa)
- [Bora Pharmaceuticals Injectables Inc](https://www.keypedia.com/companies/bora-pharmaceuticals-injectables-inc/d6e15b21-41fb-4f18-9638-893d3f44fcd1)
- [Hospira, Inc., A Pfizer Company](https://www.keypedia.com/companies/hospira-inc-a-pfizer-company/46d63c80-caf7-40db-8325-13fcade5e82c)
- [Catalent Belgium SA](https://www.keypedia.com/companies/catalent-belgium-sa/f48653bf-84a2-4aeb-bdc3-ca2d0cc4fdf2)
- [Prime Matter Labs](https://www.keypedia.com/companies/prime-matter-labs/dddd6753-e267-4dbe-af3e-69350e9aab1c)
- [Afton Scientific, LLC](https://www.keypedia.com/companies/afton-scientific-llc/e5ec92fc-2eb5-4366-8d78-fd597c977fe8)
- [Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)](https://www.keypedia.com/companies/vetter-pharma-fertigung-gmbh-co-kg-ravensburg-mooswiesen/d0287c3d-c544-40de-aece-ba713025286c)

## Related Officers

- [Principal Consultant](https://www.keypedia.com/people/stephen-d-brown/01ff1439-f6d7-4501-a104-573dae30d306)
- [investigator](https://www.keypedia.com/people/diana-l-ayala/4646a3f6-81dc-427c-97e1-dae06ab884d3)
- [Investigator](https://www.keypedia.com/people/lucas-b-leake/f4c191d4-25d1-4eb8-8dc9-4d1aa483a441)